Back to Search
AVI AVIGDOR, PH.D
PH.D
Clinical Psychologist
NPI: 1649613506Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
020029(NY)
Research & Publications (20)
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma.
PMID 19608615·Ann Oncol·2010
3-trial
MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization.
PMID 19197139·J Clin Invest·2009
7-preclinical
Early interim PET scan in Hodgkin lymphoma: where do we stand?
PMID 18398732·Leuk Lymphoma·2008
6-review
LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.
PMID 18086797·J Clin Oncol·2008
4-observational
Ibritumomab tiuxetan (Zevalin) combined with reduced-intensity conditioning and allogeneic stem-cell transplantation (SCT) in patients with chemorefractory non-Hodgkin's lymphoma.
PMID 18026153·Bone Marrow Transplant·2008
3-trial
PET/CT in the evaluation of lymphoma in patients with HIV-1 with suppressed viral loads.
PMID 18716509·Clin Nucl Med·2008
8-other
Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations.
PMID 18460650·Haematologica·2008
8-other
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy.
PMID 17998899·Lab Invest·2008
8-other
Yttrium-90-ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphoma.
PMID 17379063·Exp Hematol·2007
3-trial
The endosteum region keeps human leukemic stem cells alive.
PMID 18938742·Cell Stem Cell·2007
7-preclinical
Gene expression profiles of AML derived stem cells; similarity to hematopoietic stem cells.
PMID 17039238·Leukemia·2006
8-other
Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: the role of dose intensity.
PMID 16307018·Leukemia·2006
3-trial
Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells.
PMID 17108140·Cancer Res·2006
8-other
Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice.
PMID 15941909·Blood·2005
7-preclinical
Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis.
PMID 15870488·Acta Haematol·2005
5-case
Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning.
PMID 15526016·Leukemia·2005
8-other
Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced.
PMID 15205669·Biol Blood Marrow Transplant·2004
8-other
Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients.
PMID 15277262·Ann Oncol·2004
8-other
Treatment for primary refractory Hodgkin's disease: a comparison of high-dose chemotherapy followed by ASCT with conventional therapy.
PMID 15094747·Bone Marrow Transplant·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8659 SANCHO ST
HOLLIS, NY 11423 - Phone
- (267) 333-1001
Quick Facts
- NPI
- 1649613506
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile